Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 49, Pages 30928-30933Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.2014058117
Keywords
Alzheimer's disease; positron emission tomography imaging; blood-brain barrier; amyloid beta (A beta) peptide; multivalent effect
Categories
Funding
- NIH [R01GM114588]
- Washington University Knight Alzheimer's Disease Research Center [NIH P50AG05681]
- McDonnell Center for Cellular and Molecular Neurobiology at Washington University School of Medicine
Ask authors/readers for more resources
Herein, we report a Cu-64 positron emission tomography (PET) imaging agent that shows appreciable in vivo brain uptake and exhibits high specific affinity for beta-amyloid (A beta) aggregates, leading to the successful PET imaging of amyloid plaques in the brains of 5xFAD mice versus those of wild-type mice. The employed approach uses a bifunctional chelator with two A beta interacting fragments that dramatically improves the A beta-binding affinity and lipophilicity for favorable blood-brain barrier penetration, while the use of optimized-length spacers between the Cuchelating group and the A beta-interacting fragments further improves the in vivo A beta-binding specificity and brain uptake of the corresponding Cu-64 PET imaging agent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available